Make your money go further for just 25p per day

AIM IHT

Settlement disappoints | FDA approvals encourage

06/06/2023 · Advanced Medical Solutions (AMS)  · Anexo (ANX)  · Diaceutics PLC (DXRX)  · Tristel (TSTL)  · Watkin Jones (WJG) 

AIM AIM Inheritance Tax potential UK

Tristel spray

Updates covered here include news of a cash settlement for an unloved legal services business, a significant forward sale for an equally unloved developer and approvals for two more highly rated companies supporting the health sector. Read on here for this and other news.


Diaceutics: significant contract award

Diaceutics (AIM: DXRX), a technology and solutions provider to the pharmaceutical industry, announced a three-year enterprise contract with a US-based top 10 global pharmaceutical company.

The contract will initially deliver US$10.1m of revenue over a three-year period, however, there are additional options which, if exercised, would significantly increase the scope and value over this period. Revenue is expected to be recognised on a monthly basis, spread broadly evenly…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login


Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Advanced Medical Solutions

Gold winner | Entrepreneurial success | CEO suspension

19/03/2025 · Company Insights

There are plenty of excellent results from AIM covered here, but we are surprised a pawnbroker…


Medical advances | Stonking Small Cap update | Measured growth

15/01/2025 · Company Insights

News covered here includes our assessment of excellent results from a diversified financial services provider and…


More on Anexo

Cosmetic ambiguity | Public sector winner and loser

07/02/2025 · Company Insights

News covered here includes our assessment of the latest trading update from a cosmetics group which…


Episode 16 of the Investor’s Champion Podcast

04/05/2024 · Podcasts

In this episode of the Investor’s Champion Podcast Chris and Lee run through key news from…


More on Diaceutics PLC

Settlement disappoints | FDA approvals encourage

06/06/2023 · Company Insights

Updates covered here include news of a cash settlement for an unloved legal services business, a…


What is AIM’s exposure to Silicon Valley Bank?

14/03/2023 · Company Insights

One of AIM’s largest companies announced cracking full year results with a big increase in its…


More on Tristel

Challenges in the US | Plenty to like

24/02/2025 · Company Insights

The US market is a key area of focus for a company covered here supporting the…


Insolvency solvency | Family fortunes | US delays

17/12/2024 · Company Insights

News covered here includes our assessment of results from one of AM’s corporate undertakers. We are…


More on Watkin Jones

Dependable is downgraded | Enough fairy tales | Promising results

24/01/2025 · Company Insights

The positive start to the year reported by the majority of AIM companies we follow has…


Bonkers Bargain receives an offer | Tough to understand

22/05/2024 · Company Insights

The takeover approaches for UK small caps continue, this time for one of our Bonkers Bargain opportunities.…


More Company Insights

Big share price move | Cyber impact | Wine wonders

Record breaking | Back catalogue success | Bonkers Bargains

Bonkers Bargains: resilience in a tough market

26/03/2025 · Michelmersh Brick

Sign-up to our free email updates

SIGN UP